In addition to atherosclerotic disease (coronary and peripheral artery disease), aortic disease constitute an important spectrum of arterial diseases such as aortic aneurysms (aortic arch, thoracoabdominal and abdominal aorta), acute aortic syndromes (aortic dissection, intramural hematoma, penetrating atherosclerotic ulcer and traumatic aortic injury), as well as genetic diseases (Marfan syndrome etc) and congenital abnormalities including the coarctation of the aorta. Best medical treatment is the initial step for a successful patients’ management.
During the past decade, endovascular aortic repair has been increasingly used to treat most of those conditions when intervention has been necessary, offering encouraging outcomes in terms of mortality and morbidity compared to open surgical repair.
Many endovascular techniques and devices have been developed and assessed during such as arch branch devices, fenestrated thoracic devices, fenestrated and branched devices for thoracoabdominal aortic repair or new devices for infra-renal aortic disease and many other devices and techniques. The main aim in most cases is either to exclude the aneurysm, or the dissected part of the aorta in order to protect patients from further complications.
In this issue we intend to illustrate with original articles and systematic reviews what are the current challenges after endovascular treatment of aortic diseases and the outcomes either early- and mid-term ones from novel devices or long-term from established devices and techniques.
In addition to atherosclerotic disease (coronary and peripheral artery disease), aortic disease constitute an important spectrum of arterial diseases such as aortic aneurysms (aortic arch, thoracoabdominal and abdominal aorta), acute aortic syndromes (aortic dissection, intramural hematoma, penetrating atherosclerotic ulcer and traumatic aortic injury), as well as genetic diseases (Marfan syndrome etc) and congenital abnormalities including the coarctation of the aorta. Best medical treatment is the initial step for a successful patients’ management.
During the past decade, endovascular aortic repair has been increasingly used to treat most of those conditions when intervention has been necessary, offering encouraging outcomes in terms of mortality and morbidity compared to open surgical repair.
Many endovascular techniques and devices have been developed and assessed during such as arch branch devices, fenestrated thoracic devices, fenestrated and branched devices for thoracoabdominal aortic repair or new devices for infra-renal aortic disease and many other devices and techniques. The main aim in most cases is either to exclude the aneurysm, or the dissected part of the aorta in order to protect patients from further complications.
In this issue we intend to illustrate with original articles and systematic reviews what are the current challenges after endovascular treatment of aortic diseases and the outcomes either early- and mid-term ones from novel devices or long-term from established devices and techniques.